Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy in Huntington's disease.

Stephen B Dunnett1, Anne E Rosser

  • 1School of Biosciences, Cardiff University, Cardiff CF10 3US, Wales, United Kingdom. dunnett@cf.ac.uk

Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|February 18, 2005
PubMed
Summary

Huntington's disease involves progressive neurodegeneration due to a genetic mutation. This review explores cellular repair strategies, including stem cell therapies and gene therapy, for Huntington's disease treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.

Nature medicine·2025
Same author

Imaging of human stem cell-derived dopamine grafts correlates with behavioural recovery and reveals microstructural brain changes.

Neurobiology of disease·2025
Same author

Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Using gene or cell therapies to treat Huntington's disease.

Handbook of clinical neurology·2024
Same author

Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease.

BMJ open·2024

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Huntington's disease is an autosomal dominant genetic disorder causing progressive neuronal degeneration, primarily in the neostriatum and neocortex.
  • The underlying genetic mutation (CAG expansion in the htt gene) is known, but mechanisms of neuronal cell death and striatal neuron targeting remain unclear.
  • Effective cellular repair strategies are crucial for treating affected individuals, complementing efforts to inhibit disease development.

Purpose of the Study:

  • To review and compare alternative cell therapies for Huntington's disease.
  • To assess the rationale and efficacy of various therapeutic approaches.
  • To provide an overview of ongoing clinical trials.

Main Methods:

  • Review of existing literature on cell-based therapies for Huntington's disease.

Related Experiment Videos

  • Analysis of therapeutic strategies including embryonic tissue transplantation, stem cell differentiation, and gene therapy.
  • Comparison of in vivo and ex vivo gene therapy approaches for delivering neuroprotective factors.
  • Examination of animal models (excitotoxic/metabolic lesions, transgenic mice) used for testing therapies.

    • Main Results:

    • Several alternative therapeutic strategies show promise for Huntington's disease.
    • Transplantation of embryonic striatal tissues and stem cell-derived striatal-like cells offer potential for cellular repair.
    • Gene therapy, both in vivo and ex vivo, is being investigated for delivering neuroprotective growth factors.
    • Ongoing pilot and experimental clinical trials are evaluating the efficacy of these approaches.

    Conclusions:

    • Cellular repair strategies represent a vital avenue for Huntington's disease treatment.
    • Stem cell therapies and gene therapy are promising approaches currently under clinical investigation.
    • Further research and clinical trials are necessary to establish the definitive efficacy of these alternative therapies.